Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 09-2019 | 06-2019 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -15,020 | -920 |
| Depreciation Amortization | N/A | N/A | N/A | 1,280 | 840 |
| Other Working Capital | N/A | N/A | N/A | 0 | -18,500 |
| Other Operating Activity | 0 | 0 | 0 | -12,520 | 1,780 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $-26,260 | $-16,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -650 | -460 |
| Other Investing Activity | 0 | 0 | 0 | -350 | -110 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1,000 | $-570 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 450 | -190 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $450 | $-190 |
| Exchange Rate Effect | N/A | N/A | N/A | -50 | 60 |
| Beginning Cash Position | N/A | N/A | N/A | 109,110 | 112,800 |
| End Cash Position | N/A | N/A | N/A | 82,240 | 95,290 |
| Net Cash Flow | $N/A | $N/A | $N/A | $-26,860 | $-17,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | -26,260 | -16,800 |
| Free Cash Flow | 0 | 0 | 0 | -26,260 | -16,800 |